Evidence base: HIV

The latest clinical trials, guidelines and resources to help in the management of HIV.

T-lymphocyte blood cell (green) infected with HIV (Photograph: SPL)
T-lymphocyte blood cell (green) infected with HIV (Photograph: SPL)

CLINICAL TRIALS

1. The strategic management of antiretroviral therapy (SMART)4 trial confirmed that untreated HIV patients have increased HIV-related morbidity and mortality with declining CD4 counts, but also increased mortality attributed to conditions that have previously not been recognised to be HIV-related, such as non-AIDS malignancies.

This trial indicated that treatment-naive patients, or those who were not receiving treatment for the previous six months, had a risk of opportunistic infection or serious non-AIDS event of seven per 100 patient-years compared with 1.6 per 100 patient-years in the virological suppression arm.

This trial strongly supports the lifelong continuation of antiretroviral treatment and discourages 'drug holidays'.

2. AIDS Clinical Trial Group 5142 was an open label randomised trial which showed that efavirenz was potent long term at high viral loads when compared with a boosted protease inhibitor. (N Engl J Med 2008; 358: 2095-106).

Therefore the non-nucleoside analogue efavirenz remains alongside the nucleoside analogue backbone, a first choice regimen when starting antiretrovirals.


GUIDELINES

1. UK National HIV testing guidelines 2008. These guidelines emphasise that HIV is treatable and patients with HIV indicator diseases should be offered an HIV test. www.bhiva.org/documents/Guidelines/Testing/GlinesHIVTest08.pdf

2. BHIVA published and approved guidelines in 2008 www.bhiva.org


KEY TEXT

Madge S, Matthews P, Singh S et al. Management of HIV in Primary Care. Medical Foundation for AIDS and Sexual Health. (revised April 2005 and downloadable at www.medfash.org) 


CURRICULUM

The RCGP covers this topic in statement 11 Sexual Health


ONLINE

1. Health Protection Agency www.hpa.org.uk. Further epidemiology data on HIV can be found under topics AIDS/HIV.

2. Guidance on various drug interactions can be found at www.hiv-druginteractions.org
 
Contributed by Dr Charlotte Hopkins and Dr R Monica Lascar, consultants in HIV and genitourinary medicine at Whipps Cross University Hospital, London.

GP Online recommends

Evidence-based practice

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NHS England pledges £30m for GPs to boost long COVID diagnosis and care

NHS England pledges £30m for GPs to boost long COVID diagnosis and care

NHS England has promised £30m for general practice to improve diagnosis and care...

Second dose COVID jabs for over-40s to be accelerated as lifting restrictions is delayed

Second dose COVID jabs for over-40s to be accelerated as lifting restrictions is delayed

Second doses of COVID-19 vaccines in England will be 'accelerated' for all over-40s...

BMA backs negligence action against GMC and hospital over doctor's suicide

BMA backs negligence action against GMC and hospital over doctor's suicide

The BMA is supporting legal action over alleged negligence and under the Human Rights...

GPs recognised in Queen's birthday honours

GPs recognised in Queen's birthday honours

GPs are among those who have been recognised in the Queen's birthday honours.

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

The healthcare crisis in Myanmar - how UK GPs can help

The healthcare crisis in Myanmar - how UK GPs can help

Dr Jim Brockbank from Myanmar UK GP Health Action provides an update on how the military...